Abstract Objective To study the efficacy and safety of lactase additive in improving lactose intolerance in preterm infants. Methods A total of 60 preterm infants with lactose intolerance who were admitted to the Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine from January 2018 to December 2019 were randomly divided into a lactase treatment group and a control group, with 30 infants in each group. The infants in the lactase treatment group were given 4 drops of lactase additive (180 mg) added into preterm formula or breast milk, and those in the control group were given placebo, oral administration of probiotics (live combined Bifidobacterium, Lactobacillus and Enterococcus powder) at half an hour after feeding (1 g each time, twice a day), and clockwise abdominal massage around the belly button at 1 hour after feeding for 15 minutes each time, 3 times a day. Fecal pH, fecal reducing sugar, growth indicators, symptoms of lactose intolerance, and laboratory markers were measured at the end of the first and second weeks after intervention. Results Finally 29 infants in the lactase treatment group and 26 infants in the control group completed the trial. At the end of the first week after intervention, compared with the control group, the lactase treatment group had significantly lower frequency of daily milk vomiting and gastric retention amount (P < 0.05) and a significantly higher proportion of infants with fecal pH > 5.0 (P < 0.05). At the end of the second week after intervention, compared with the control group, the lactase treatment group had significantly lower frequency of daily milk vomiting and 24-hour abdominal circumference difference (P < 0.05) and a significantly higher proportion of infants with the absence of gastric retention, fecal pH > 5.0, or negative reducing sugar in feces (P < 0.05). No adverse reactions associated with the lactase additive or probiotics were observed during the trial. Conclusions Lactase additive can safely and effectively improve the clinical symptoms caused by lactose intolerance in preterm infants.
WANG Li,WANG Yi-Wen,TAN Jin-Tong et al. Efficacy and safety of lactase additive in preterm infants with lactose intolerance: a prospective randomized controlled trial[J]. CJCP, 2021, 23(7): 671-676.
WANG Li,WANG Yi-Wen,TAN Jin-Tong et al. Efficacy and safety of lactase additive in preterm infants with lactose intolerance: a prospective randomized controlled trial[J]. CJCP, 2021, 23(7): 671-676.
Heine RG, AlRefaee F, Bachina P, et al. Lactose intolerance and gastrointestinal cow's milk allergy in infants and children-common misconceptions revisited[J]. World Allergy Organ J, 2017, 10(1):41. DOI:10.1186/s40413-017-0173-0. PMID:29270244. PMCID:PMC5726035.
[2]
Szilagyi A, Ishayek N. Lactose intolerance, dairy avoidance, and treatment options[J]. Nutrients, 2018, 10(12):1994. DOI:10.3390/nu10121994. PMID:30558337. PMC6316316.
Silberman ES, Jin J. Lactose intolerance[J]. JAMA, 2019, 322(16):1620. DOI:10.1001/jama.2019.9608. PMID:31638683.
[8]
Shulman RJ, Wong WW, Smith EO. Influence of changes in lactase activity and small-intestinal mucosal growth on lactose digestion and absorption in preterm infants[J]. Am J Clin Nutr, 2005, 81(2):472-479. DOI:10.1093/ajcn.81.2.472. PMID:15699237.
[9]
Heyman MB, Committee on Nutrition. Lactose intolerance in infants, children, and adolescents[J]. Pediatrics, 2006, 118(3):1279-1286. DOI:10.1542/peds.2006-1721. PMID:16951027.
[10]
Vandenplas Y. Lactose intolerance[J]. Asia Pac J Clin Nutr, 2015, 24(Suppl 1):S9-S13. DOI:10.6133/apjcn.2015.24.s1.02. PMID:26715083.
[11]
Griffin MP, Hansen JW. Can the elimination of lactose from formula improve feeding tolerance in premature infants?[J]. J Pediatr, 1999, 135(5):587-592. DOI:10.1016/s0022-3476(99)70057-0. PMID:10547247.
[12]
Szajewska H. Extensive and partial protein hydrolysate preterm formulas[J]. J Pediatr Gastroenterol Nutr, 2007, 45(Suppl 3):S183-S187. DOI:10.1097/01.mpg.0000302969.60373.39. PMID:18185089.
Misselwitz B, Butter M, Verbeke K, et al. Update on lactose malabsorption and intolerance:pathogenesis, diagnosis and clinical management[J]. Gut, 2019, 68(11):2080-2091. DOI:10.1136/gutjnl-2019-318404. PMID:31427404. PMCID:PMC6839734.
[16]
Erasmus HD, Ludwig-Auser HM, Paterson PG, et al. Enhanced weight gain in preterm infants receiving lactase-treated feeds:a randomized, double-blind, controlled trial[J]. J Pediatr, 2002, 141(4):532-537. DOI:10.1067/mpd.2002.127499. PMID:12378193.
Pereira-da-Silva L, Dias MP, Virella D, et al. Osmolality of preterm formulas supplemented with nonprotein energy supplements[J]. Eur J Clin Nutr, 2008, 62(2):274-278. DOI:10.1038/sj.ejcn.1602736. PMID:17375112.
Hodges JK, Cao SS, Cladis DP, et al. Lactose intolerance and bone health:the challenge of ensuring adequate calcium intake[J]. Nutrients, 2019, 11(4):718. DOI:10.3390/nu11040718. PMID:30925689. PMCID:PMC6521087.
